☆ 4.8 Article

Stapled peptide PROTAC induced significantly greater anti-PD-L1 effects than inhibitor in human cervical cancer cells

FRONTIERS IN IMMUNOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Chemistry, Multidisciplinary

Current strategies and progress for targeting the undruggable transcription factors

Jing-jing Zhuang et al.

Summary: Transcription factors (TFs) play essential roles in regulating biological processes and have great potential as therapeutic drug targets. Historically considered undruggable due to lack of structural information, recent progress and strategies have accelerated the development of TF-targeting drugs.

ACTA PHARMACOLOGICA SINICA (2022)

添加到收藏夹

Review Biotechnology & Applied Microbiology

PROTAC targeted protein degraders: the past is prologue

Miklos Bekes et al.

Summary: Targeted protein degradation (TPD) is a new therapeutic modality that can tackle disease-causing proteins which are difficult to target with conventional small molecules. PROTAC molecules, utilizing the ubiquitin-proteasome system to degrade target proteins, has achieved clinical proof-of-concept and attracted significant industry activity. Future directions include identifying target classes suitable for TPD, expanding the use of ubiquitin ligases for precision medicine, and extending the modality beyond oncology.

NATURE REVIEWS DRUG DISCOVERY (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer

Nathalie Broutet et al.

Summary: To achieve the goal of eliminating cervical cancer, countries need to rethink the implementation of new technologies and treatment interventions. Implementation research plays a crucial role in facilitating the scale-up of evidence-based screening and treatment interventions. Additionally, support from international organizations provides opportunities to evaluate different approaches and strategies.

PREVENTIVE MEDICINE (2022)

添加到收藏夹

Review Oncology

The role of cell-penetrating peptides in potential anti-cancer therapy

Meiling Zhou et al.

Summary: Cell-penetrating peptides (CPPs), as potential choices for oncology treatment, can be used as molecular transporters to facilitate drug delivery across physiological barriers. However, their limitations in terms of cell specificity, stability, and other factors need to be addressed through clever design or chemical modifications.

CLINICAL AND TRANSLATIONAL MEDICINE (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Assessing the Future of Solid Tumor Immunotherapy

Prajna Guha et al.

Summary: Cancer immunotherapy has significantly improved the quality of life and survival of patients with the advent of CAR-T cell therapy and immune checkpoint inhibitors. However, the application of immunotherapy in solid tumors faces several barriers. This review proposes specific approaches to overcome these barriers and improve outcomes for solid tumor patients receiving immunotherapies.

BIOMEDICINES (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future

Rui Li et al.

Summary: PROteolysis TArgeting Chimeras (PROTACs) is an innovative technique that selectively degrades target proteins via the ubiquitin-proteasome system, offering advantages over traditional protein inhibitor drugs in terms of efficacy, selectivity, and overcoming drug resistance in cancer therapy. In this review, we comprehensively discuss the historical milestones, structures, mechanisms, and application of PROTACs in targeting tumor-related targets. We also provide a list of representative PROTACs based on CRBN, VHL, MDM2, or cIAP1 E3 ligases, as well as those undergoing clinical trials for anti-cancer activity.

MOLECULES (2022)

添加到收藏夹

Editorial Material Cell Biology

High-potency PD-1/PD-L1 degradation induced by Peptide-PROTAC in human cancer cells

Meng-Yuan Dai et al.

CELL DEATH & DISEASE (2022)

添加到收藏夹

Review Oncology

PROTACs: Current Trends in Protein Degradation by Proteolysis-Targeting Chimeras

Jyotsana Madan et al.

Summary: PROTAC technology has gained attention for its ability to overcome limitations of protein inhibitors and target undruggable proteins. The technology consists of three components: a ubiquitin E3 ligase ligand, a linker, and a target protein ligand. It has shown promise in cancer therapy.

BIODRUGS (2022)

添加到收藏夹

Review Chemistry, Medicinal

REVIEW Emerging Therapeutic Strategies of Different Immunotherapy Approaches Combined with PD-1/PD-L1 Blockade in Cervical Cancer

Yanjun Ge et al.

Summary: Currently, therapeutic options for advanced and recurrent cervical cancer patients are limited. Immunotherapy shows promise in cancer treatment, but research and application in cervical cancer have been slow. Although pembrolizumab, the first anti-PD-1 monoclonal antibody approved by the FDA for treating cervical cancer, has been a significant milestone, it has a relatively low response rate. Multiple novel immune checkpoints, such as CTLA-4, TIGIT, LAG-3, TIM-3, and A2AR, have emerged in recent years. Studies have suggested that combining PD-1/PD-L1 inhibitors with different immunotherapies or biotherapies can enhance the antitumor efficacy in human cancers.

DRUG DESIGN DEVELOPMENT AND THERAPY (2022)

添加到收藏夹

Review Chemistry, Multidisciplinary

Target and tissue selectivity of PROTAC degraders

Robert G. Guenette et al.

Summary: Targeted protein degradation strategies, such as PROTAC and molecular glue technology, have provided highly selective control of target inhibition, revolutionizing the approach to challenging protein targets. These advancements have broad implications in treating diseases by expanding the range of possible targets that can be addressed by small molecules.

CHEMICAL SOCIETY REVIEWS (2022)

添加到收藏夹

Review Oncology

Targeted Protein Degradation: An Important Tool for Drug Discovery for Undruggable Tumor Transcription Factors

Mengyuan Dai et al.

Summary: Conventional small-molecule drugs play an important role in cancer treatment, but some types of tumor targets, such as transcription factors, are difficult to target. Therefore, exploring new technologies is needed to address these challenges.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Targeted protein degradation: mechanisms, strategies and application

Lin Zhao et al.

Summary: Traditional drug discovery focuses on direct regulation of protein activity. However, the emerging targeted protein degradation (TPD) technologies, such as PROTAC, provide potential approaches to remove disease-associated proteins by utilizing cells' degradation machinery. These TPD strategies, including molecular glue, LYTAC, and AbTAC, expand the scope of TPD and offer fresh insights into drug discovery.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

添加到收藏夹

Review Chemistry, Multidisciplinary

Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway

Qian Wu et al.

Summary: PD-1/PD-L1 signaling pathway is a target for anticancer drugs, and the development of small molecule inhibitors provides a new avenue for tumor immunotherapy.

ACTA PHARMACOLOGICA SINICA (2021)

添加到收藏夹

Article Immunology

Immune checkpoint expression on peripheral cytotoxic lymphocytes in cervical cancer patients: moving beyond the PD-1/PD-L1 axis

F. Solorzano-Ibarra et al.

Summary: The study showed that the expression of TIGIT, Tim-3, and PD-1 was significantly increased in patients with cervical cancer, accompanied by the phenomenon of "exhausted" NK and T cells. Soluble PD-L1 was elevated in the blood of patients and positively correlated with PD-1(+) T cells. When compared to healthy donors, sPD-L1 showed a negative correlation with total T cells and a positive correlation with CD56(dim) NK cells.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2021)

添加到收藏夹

Article Oncology

Targeting an Inducible SALL4-Mediated Cancer Vulnerability with Sequential Therapy

Junyu Yang et al.

Summary: The study suggests inducing vulnerability mediated by SALL4 as a therapeutic approach for patients with no suitable target. By partially engineering cancer cells' dependency on SALL4, transient target induction and engineering dependency can sensitize cancer cells to treatment.

CANCER RESEARCH (2021)

添加到收藏夹

Article Oncology

Pembrolizumab for advanced cervical cancer: safety and efficacy

Francesca De Felice et al.

Summary: Pembrolizumab shows promise in the treatment of cervical cancer, especially in patients with PD-L1 expression. Further research is needed to better identify patients who will benefit the most.

EXPERT REVIEW OF ANTICANCER THERAPY (2021)

添加到收藏夹

Article Behavioral Sciences

Fluoxetine and Ketamine Reverse the Depressive but Not Anxiety Behavior Induced by Lesion of Cholinergic Neurons in the Horizontal Limb of the Diagonal Band of Broca in Male Rat

Linghong Chen et al.

Summary: The study revealed that a lesion of HDB cholinergic neurons in rats led to depressive and anxiety-like behaviors. Antidepressants such as fluoxetine or ketamine could reverse depressive-like behaviors but not anxiety-like behaviors.

FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2021)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Advances in targeting 'undruggable' transcription factors with small molecules

Matthew J. Henley et al.

Summary: Transcription factors play important roles in various diseases and recent advancements in chemical biology have provided new possibilities for targeting TFs with small molecules. However, challenges remain, such as addressing structural disorder and finding appropriate targeting strategies.

NATURE REVIEWS DRUG DISCOVERY (2021)

添加到收藏夹

Review Oncology

The Next Decade of Immune Checkpoint Therapy

Padmanee Sharma et al.

Summary: Immune checkpoint therapy can provide durable antitumor responses for subsets of cancer patients, but challenges remain in understanding resistance mechanisms, optimizing patient selection, managing immune-related adverse events, and identifying rational therapeutic combinations. A focused approach encompassing clinical and basic research with integration of reverse translational studies is needed to address these challenges and guide the development of novel combination strategies.

CANCER DISCOVERY (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

The PROTACtable genome

Melanie Schneider et al.

Summary: This article presents a systematic approach to assessing the PROTAC tractability of protein targets, which could support decision-making on whether a particular target may be amenable to modulation using a PROTAC.

NATURE REVIEWS DRUG DISCOVERY (2021)

添加到收藏夹

Review Medicine, General & Internal

Peptide-Based Drug Delivery Systems

Dmitriy Berillo et al.

Summary: Peptide-based drug delivery systems offer advantages over synthetic systems in terms of biocompatibility, lack of toxicity, and controlled molecular weight. Various peptide-based carriers have been used to deliver toxic drugs, with a focus on anticancer medications, and efforts are being made to develop controlled drug delivery systems for improved outcomes.

MEDICINA-LITHUANIA (2021)

添加到收藏夹

Article Medicine, Research & Experimental

A nano-predator of pathological MDMX construct by clearable supramolecular gold(I)-thiol-peptide complexes achieves safe and potent anti-tumor activity

Siqi Yan et al.

Summary: This study designed a peptide-based molecular glue to target the tumor-driving protein MDMX for degradation, restoring the anti-cancer function of p53 and p73. The nanoengineered complex exhibited potent anti-cancer activities in animal models and maintained a favorable safety profile, bridging the gap between peptides and PROTACs for potential development in disease treatment.

THERANOSTICS (2021)

添加到收藏夹

Review Infectious Diseases

SARS-CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges

Andrew R. McGill et al.

Summary: SARS-CoV-2 is a novel coronavirus that emerged from Wuhan, China in late 2019, causing COVID-19, with various potential receptors for attachment. The spectrum of infection pathology ranges from asymptomatic to severe respiratory distress syndrome, with dysregulated immune responses and decreasing antibody titers. Treatment options for COVID-19 include immunotherapies, peptide therapies, and nucleic acid vaccines.

INFECTIOUS DISEASE REPORTS (2021)

添加到收藏夹

Review Oncology

A review of cancer immunotherapy toxicity

Lucy Boyce Kennedy et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Preventive and Therapeutic Effects of Astaxanthin on Depressive-Like Behaviors in High-Fat Diet and Streptozotocin-Treated Rats

Yuting Ke et al.

FRONTIERS IN PHARMACOLOGY (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis

Marc Arbyn et al.

LANCET GLOBAL HEALTH (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Preparation of Biphenyl-Conjugated Bromotyrosine for Inhibition of PD-1/PD-L1 Immune Checkpoint Interactions

Eun-Hye Kim et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Article Cell Biology

A PROTAC peptide induces durable β-catenin degradation and suppresses Wnt-dependent intestinal cancer

Hongwei Liao et al.

CELL DISCOVERY (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Recent trends in protein and peptide-based biomaterials for advanced drug delivery

Anastasia Varanko et al.

ADVANCED DRUG DELIVERY REVIEWS (2020)

添加到收藏夹

Review Oncology

Study and analysis of antitumor resistance mechanism of PD1/PD-L1 immune checkpoint blocker

Zhengyi Wang et al.

CANCER MEDICINE (2020)

添加到收藏夹

Review Immunology

The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment

Katie Hudson et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Trappc9 deficiency in mice impairs learning and memory by causing imbalance of dopamine D1 and D2 neurons

Yuting Ke et al.

SCIENCE ADVANCES (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

CA-170-A Potent Small-Molecule PD-L1 Inhibitor or Not?

Bogdan Musielak et al.

MOLECULES (2019)

添加到收藏夹

Review Pharmacology & Pharmacy

Cervical Cancer, Different Treatments and Importance of Bile Acids as Therapeutic Agents in This Disease

Tanja Sarenac et al.

FRONTIERS IN PHARMACOLOGY (2019)

添加到收藏夹

Article Chemistry, Multidisciplinary

Computational Insight Into the Small Molecule Intervening PD-L1 Dimerization and the Potential Structure-Activity Relationship

Danfeng Shi et al.

FRONTIERS IN CHEMISTRY (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Hitting Undruggable Targets: Viewing Stabilized Peptide Development through the Lens of Quantitative Systems Pharmacology

Lydia Atangcho et al.

TRENDS IN BIOCHEMICAL SCIENCES (2019)

添加到收藏夹

Review Oncology

Systemic therapy for cervical carcinoma - current status

Krystyna Serkies et al.

CHINESE JOURNAL OF CANCER RESEARCH (2018)

添加到收藏夹

Review Oncology

Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis

Niloy Ranjan Datta et al.

GYNECOLOGIC ONCOLOGY (2017)

添加到收藏夹

Article Oncology

Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1-Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial

Jean-Sebastien Frenel et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

添加到收藏夹

Article Oncology

Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells

Lukasz Skalniak et al.

ONCOTARGET (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum

Roland Boettger et al.

PLOS ONE (2017)

添加到收藏夹

Article Neurosciences

Phospholipase C gamma mediates endogenous brain-derived neurotrophic factor-regulated calcitonin gene-related peptide expression in colitis-induced visceral pain

Fiza Hashmi et al.

MOLECULAR PAIN (2016)

添加到收藏夹

Article Neurosciences

INFLAMMATION AND ACTIVITY AUGMENT BRAIN-DERIVED NEUROTROPHIC FACTOR PERIPHERAL RELEASE

L. Y. Qiao et al.

NEUROSCIENCE (2016)

添加到收藏夹

Review Medicine, General & Internal

Impact of V-ets Erythroblastosis Virus E26 Oncogene Homolog 1 Gene Polymorphisms Upon Susceptibility to Autoimmune Diseases A Meta-Analysis

Ye Zhou et al.

MEDICINE (2015)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Statistical Issues in Longitudinal Data Analysis for Treatment Efficacy Studies in the Biomedical Sciences

Chunyan Liu et al.

MOLECULAR THERAPY (2010)

添加到收藏夹

Review Oncology

The epidemiology of cervical cancer

EL Franco et al.

CANCER JOURNAL (2003)

添加到收藏夹

Review Medicine, General & Internal

Cervical cancer

SE Waggoner

LANCET (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.